Participants will gain insight into covered entity (CE) perspectives of why biosimilars are important to patient care and how contracts can impact distribution and payer decisions. Manufacturers will learn how contracting with the PVP may align with their brand strategies at various stages of the product lifecycle, including:
Thursday, July 29
12:00–1:00 PM CDT
Webinar
John Barnes, CPM, MBA, 340B ACE
Associate Vice President Contract Services, 340B PVP, Apexus
Jaime Barouh
National Key Account Manager at Morris & Dickson Co., LLC
Cam Bivens
Sr. Director, National Accounts Institutional at Teva Pharmaceuticals
Victoria Dubé
Sr. Director, National Accounts - GPO at Coherus BioSciences
Michael O’Neal PharmD, MBA
Director of Pharmacy Procurement & Inventory Management at Vanderbilt University Medical Center
For questions, or to request additional information regarding specific 340B Prime Vendor Program services or programs offered by Apexus, please see contact information below:
888 340 BPVP (2787)
8:00 a.m.- 5:00 p.m. CT
The 340B PVP Manufacturer Refund Service (MRS) facilitates refunds to covered entities by refunding directly to affected facilities, primarily through its authorized distribution network.
Read our article about 340B regulatory changes and their impact, as well as best practices for manufacturers.
The Prime Vendor supports the HRSA 340B Drug Pricing Program as a voluntary program for covered entities and manufacturers.
Partner with the 340B PVP to support mutual customers.
Learn essential manufacturer compliance elements of the 340B Program at no cost, 24/7. Module descriptions available here.
Proactively prepare the information you may need for a HRSA audit using the PVP’s Sample HRSA 340B Audit Data Request for Manufacturers.
Access common terms used in the 340B Program and their definitions.
The 340B PVP nationwide distribution network facilitates covered entity product access and compliance.
Find out more about what we do and how we can help you.